Sarcoid-like Histiocytic Proliferations in Patients With Lymphoma Can Be FDG-avid Concerning for Refractory or Recurrent Disease

Clin Lymphoma Myeloma Leuk. 2019 Nov;19(11):e597-e601. doi: 10.1016/j.clml.2019.08.016. Epub 2019 Aug 30.

Authors

Zuzan Cayci¹, Kerem Ozturk², Celalettin Ustun³, Aazim K Omer³, Erhan Dincer⁴, Zohar Sachs³, Bruce A Peterson³, Michael A Linden⁵

Affiliations

¹ Department of Radiology, University of Minnesota, Minneapolis, MN. Electronic address: [email protected].
² Department of Radiology, University of Minnesota, Minneapolis, MN.
³ Division of Hematology-Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN.
⁴ Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN.
⁵ Division of Hematopathology, Department of Pathology and Laboratory Medicine, University of Minnesota, Minneapolis, MN.

PMID: 31548163
DOI: 10.1016/j.clml.2019.08.016

No abstract available

Keywords: 18F-Fluorodeoxyglucose (FDG); Computed tomography (CT); Lymphoma; Sarcoid-like reaction; Sarcoidosis.

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biomarkers
Cyclophosphamide / adverse effects
Cyclophosphamide / therapeutic use
Doxorubicin / adverse effects
Doxorubicin / therapeutic use
Female
Fluorodeoxyglucose F18*
Histiocytes / pathology*
Humans
Immunohistochemistry
Lymphoma / drug therapy*
Lymphoma / pathology*
Lymphoma / therapy
Middle Aged
Neoplasm Grading
Neoplasm Staging
Positron Emission Tomography Computed Tomography* / methods
Prednisolone / adverse effects
Prednisolone / therapeutic use
Sarcoidosis / pathology*
Vincristine / adverse effects
Vincristine / therapeutic use

Substances

Biomarkers
Fluorodeoxyglucose F18
Vincristine
Doxorubicin
Cyclophosphamide
Prednisolone

Supplementary concepts

VAP-cyclo protocol